Vietnamplus

All the three COVID-19 vaccine candidates Vietnam is developing are currently in the stage of clinical trials, and if they are qualified as assessed by the ethics and advisory councils, the Ministry of Health (MoH) will grant licenses, an official has said.

Initial results of the clinical trials of ARCT-154 show that this mRNA COVID-19 vaccine is safe for healthy volunteers, an researcher said.

The Hanoi Medical University has started the first phase of clinical trials of COVID-19 vaccine ARCT-154 with the participation of 100 volunteers.

The Hanoi Medical University has started the first phase of clinical trials of COVID-19 vaccine ARCT-154 with the participation of 100 volunteers.

The Hanoi Medical University will start on August 15 Phase 1 of clinical trial of the mRNA COVID-19 vaccine named ARCT-154 vaccine with 100 volunteers from Hanoi.

The Hanoi Medical University will on August 15 start the first phase of clinical trials of COVID-19 vaccine ARCT-154, a mRNA vaccine developed by US company Arcturus Therapeutics, Inc, which transferred the technology to a company in Vietnam.